文献速递艾滋病与性传播感染

围产期HIV-1感染早期长期病毒学控制下HIV-1 DNA衰减动态

Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
PubMed 文献 · Clin Infect Dis · 2017-01-01

本研究在儿童HIV/AIDS队列研究中,对61名围产期HIV-1感染且达到病毒学抑制的青少年,纵向定量外周血单核细胞中HIV-1 DNA长达14年。结果显示病毒学抑制后前2年HIV-1 DNA每年下降0.25 log10 copies/百万PBMCs,1岁内抑制者下降更快;2至14年间每年下降0.05 log10 copies/百万PBMCs,组间无显著差异。早期有效长期ART使HIV-1感染细胞衰减至极低浓度。

要点

  • 病毒学抑制后前2年HIV-1 DNA下降较快,1岁内抑制者下降速率更高。
  • 抑制后2至14年HIV-1 DNA持续缓慢衰减,每年约0.05 log10 copies/百万PBMCs。
  • 婴儿期启动有效长期ART可使HIV-1 DNA降至极低水平。

核心结论

  • 从婴儿期开始早期有效长期ART可导致HIV-1感染细胞衰减至极低浓度,符合HIV-1缓解策略所需。

研究设计与样本

  • 儿童HIV/AIDS队列研究,纳入61名围产期HIV-1感染青少年,纵向定量PBMCs中HIV-1 DNA长达14年。
  • 组1(n=13)在<1岁达到病毒学抑制,组2(n=48)在1至5岁达到病毒学抑制。
  • 采用分段线性混合效应回归模型评估达到病毒学抑制时年龄对HIV-1 DNA轨迹的影响。

主要发现

  • 1岁内达到病毒学抑制者前2年下降速率为-0.50 log10 copies/百万PBMCs/年,1岁后为-0.15 log10 copies/百万PBMCs/年。
  • 调整CD4细胞计数对衰减估计无影响。

临床怎么用

  • 对于围产期HIV-1感染婴儿,应尽早启动有效ART以实现病毒学抑制,有助于限制HIV-1 DNA储存库。
  • 长期维持病毒学抑制可促使HIV-1 DNA持续衰减,支持HIV-1缓解策略的探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND.: Early antiretroviral therapy (ART) limits proviral reservoirs, a goal for human immunodeficiency virus type 1 (HIV-1) remission strategies. Whether this is an immediate or long-term effect of virologic suppression (VS) in perinatal infection is unknown. METHODS.: We quantified HIV-1 DNA longitudinally for up to 14 years in peripheral blood mononuclear cells (PBMCs) among 61 perinatally HIV-1-infected youths in the Pediatric HIV/AIDS Cohort Study who achieved VS at different ages. Participants in group 1 (n = 13) were <1 year of age and in group 2 (n = 48) from 1 through 5 years of age at VS. Piecewise linear mixed-effects regression models assessed the effect of age at VS on HIV-1 DNA trajectories during VS. RESULTS.: In the first 2 years following VS, HIV-1 DNA levels decreased by -0.25 (95% confidence interval [CI], -.36 to -.13) log10 copies/million PBMCs per year and was faster with early VS by age 1 year compared with after age 1 (-0.50 and -0.15 log10 copies/million PBMCs per year, respectively). Between years 2 and 14 from VS, HIV-1 DNA decayed by -0.05 (95% CI, -.06 to -.03) log10 copies/million PBMCs per year and was no longer significantly different between groups. The estimated mean half-life of HIV-1 DNA from VS was 15.9 years and was shorter for group 1 compared to group 2 at 5.9 years and 18.8 years, respectively (P = .09). Adjusting for CD4 cell counts had no effect on decay estimates. CONCLUSIONS.: Early effective, long-term ART initiated from infancy leads to decay of HIV-1-infected cells to exceedingly low concentrations desired for HIV-1 remission strategies.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Uprety P, Patel K, Karalius B, et al. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection. Clin Infect Dis. 2017. PMID: 28329153. doi:10.1093/cid/cix192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。